Global Funds: Extreme Stocks, July 2024

330 Global active equity funds, AUM $1.1tr Global Funds: Extreme Stocks Summary In this report, we screen for stocks at the extreme ends of their positioning or momentum ranges. We synthesize current and historical data on fund positioning with recent manager activity to accurately assess sentiment for each stock within our coverage. Stocks in focus this month: High Positioning, Positive …

Continue Reading

GEM Funds: Extreme Stocks, July 2024

352 Global Emerging markets active equity funds, AUM $429bn GEM Funds: Extreme Stocks Summary In this report, we screen for stocks at the extreme ends of their positioning or momentum ranges. We synthesize current and historical data on fund positioning with recent manager activity to accurately assess sentiment for each stock within our coverage. Stocks in focus this month: High …

Continue Reading

UK Funds: Performance & Attribution Review, Q2 2024

260 UK Equity funds, AUM $185bn UK Funds: Performance & Attribution Review, Q2 2024 Summary UK Funds Match Benchmark in Q2: Active UK funds achieved an average Q2 return of +3.62%, in line with the benchmark and with just over half of funds outperforming the index. Performance Correlated to Style: Performance was strongly influenced by style, with Value funds leading …

Continue Reading

China Funds: Performance & Attribution Review, Q2 2024

143 MSCI China Equity funds, AUM $38bn MSCI China Funds: Performance & Attribution Review, Q2 2024   Summary Heavy underperformance in Q2: Average returns of 3.46% lag the iShares MSCI China ETF by -3.15%, with just 11.5% of funds outperforming. Key Industry Level Positioning Costs Managers: At the industry level, 2.3% of underperformance was observed across Internet Software/Services, Alcoholic Beverages, …

Continue Reading

Global Funds: Performance & Attribution Review, Q2 2024

330 Global funds, AUM $1.1tr Global Funds: Performance & Attribution Review, Q2 2024 Summary Challenging Q2 as majority underperform: Average returns of 1.29% lag the SPDRs MSCI ACWI ETF by -2.2%, with 69% of funds underperforming. Growth beats Value: All Style groups lost out to the benchmark, with Value funds experiencing notable underperformance. USA Drives Underperformance:  Global funds once again …

Continue Reading

Asia Ex-Japan: Performance & Attribution Review, Q2 2024

99 Asia Ex-Japan active equity funds, AUM $53bn Asia Ex-Japan: Performance & Attribution Review, Q2 2024 Summary Strong Q2 Returns Match Benchmark: Average active fund returns of 6.75% match the iShares Asia Ex-Japan benchmark, with 50.8% of funds outperforming. Value beats Growth: Value and Yield funds had the edge on the quarter, with GARP funds the only Style to underperform …

Continue Reading

GEM Funds: Performance & Attribution Review, Q2 2024

352 Global Emerging markets active equity funds, AUM $429bn GEM Funds: Performance & Attribution Review, Q2 2024   Summary Strong Q2 returns but passive beats Active: Average active fund returns of 3.91% fail to beat the iShares MSCI EM ETF return of 4.39%, with 54% of funds underperforming. Growth beats Value: All Style groups underperform the benchmark on average, though …

Continue Reading

Positioning Insights & Investment Trends, June 24

332 Global Equity Funds, AUM $1.1Tr Positioning Insights & Investment Trends In this month’s report, we look at positioning in France and the United Kingdom ahead of the upcoming snap elections. We highlight a regime shift in the Industrials sector, the decline in US Consumer Staples exposure and continued outward rotation in Biotechnology stocks. Summary France: Global Funds Overweight Ahead …

Continue Reading

Positioning Insights & Investment Trends, June 24

352 emerging market Funds, AUM $424bn Positioning Insights & Investment Trends In this month’s report, we look at positioning in the 3 recent election markets of Mexico, South Africa and India, highlight the largest country/sector underweight in EM, a recovery in Turkish Financials and a drop in South Korean Materials Exposure.   Summary Mexico: GEM Funds Wrong-Footed after Election Results.  …

Continue Reading

UK Communication Services: Old Guard Fuels Sector Downturn

264 active UK equity funds, AUM $190bn UK Communication Services: Old Guard Fuels Sector Downturn Summary • Significant Decline in Sector Allocation: Exposure to the Communication Services sector among active UK investors has dropped from over 10% in 2012 to a new low of 4.14%, with a record 12% of funds completely avoiding the sector. • Widespread Reduction in Ownership: …

Continue Reading

Terms and Conditions

Investor Positioning Report — Copley Fund Research Ltd  ·  Last updated: July 2026  ·  Registered in England and Wales

1. Who we are

Copley Fund Research Ltd provides proprietary institutional fund intelligence to listed companies and investor relations professionals. These terms govern every purchase of an Investor Positioning Report. By completing a purchase you confirm you have read, understood, and agreed to these terms in full.

2. What you are purchasing

The Investor Positioning Report is a bespoke PDF report mapping the institutional fund universe around your stock. It covers current investors, past investors, competitor investors, and white space investors. Every report is built from scratch for the specific company ordered and is not a standardised or templated product.

3. Delivery and process

Following payment or invoice issuance, Copley Fund Research will contact you within one working day to agree your competitor set. Production begins once the competitor set is confirmed in writing. The completed report will be released to you within 48 hours of production starting, provided payment has been received in full; where payment is outstanding, the report will be withheld until payment clears. If the requested company falls outside our covered fund universes, or a competitor set cannot be agreed, Copley Fund Research will issue a full refund or cancel the outstanding invoice.

4. Competitor set agreement

The competitor set is agreed with you in writing prior to production, and the report is built to that agreed specification. Requests to amend the competitor set after delivery, based on a change of preference rather than an error, may be treated as a new order.

5. Refund policy

Because each report is produced individually for your company, orders are non-refundable once production has begun, except as set out in clauses 3 and 5a below. By purchasing, you agree not to dispute the charge with your card provider on the basis that the service was not as described, provided the report has been delivered to the agreed specification or corrected under clause 5a.

5a. Quality remedy

If a delivered report contains a material error caused by Copley Fund Research — for example, an incorrect company analysed, a competitor omitted from the agreed set, or content missing from the specification in clause 2 — Copley Fund Research will correct and redeliver the report at no additional charge, within a reasonable timeframe. This is your sole remedy for such errors.

6. Data and accuracy

All fund positioning data in the report reflects holdings as disclosed at the most recently available reporting date at the time of compilation. The timing of fund holdings disclosures is determined by regulatory requirements applicable to each fund and is outside the control of Copley Fund Research Ltd. This data may not reflect current fund positions. Copley Fund Research takes reasonable care to ensure accuracy but makes no warranty, express or implied, as to the completeness or current accuracy of the underlying data — though this does not affect the quality remedy in clause 5a for errors in how that data was analysed or presented. Past fund positioning is not indicative of future fund behaviour or investment decisions.

7. Not investment advice

The Investor Positioning Report is produced for investor relations intelligence purposes only. It does not constitute investment advice, financial advice, or a recommendation to buy, hold, or sell any security. The data reflects historical fund positioning and must not be relied upon as a prediction of future fund behaviour or investment decisions. Copley Fund Research Ltd is not authorised or regulated by the Financial Conduct Authority for the provision of investment advice.

8. Permitted use and confidentiality

The report is licensed for internal use by the purchasing organisation only. You may share it with employees and directors of your organisation. You may not: reproduce, redistribute, publish, or resell the report or any part of it; share it with any third party outside your organisation without prior written consent; use the fund or portfolio manager names contained in the report to approach those individuals on behalf of Copley Fund Research or in a manner that could damage Copley Fund Research's relationships with those funds; or use the data for any purpose other than your own investor relations strategy. The data, analysis, and methodology contained in the report are the intellectual property of Copley